SCHEMBL3575867

SCHEMBL3575867

CCOC(=O)C1=C(c2ccccc2)c2cc3c(cc2C1=O)OCO3

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 8/20 0.63
ALDH1A1 P00352 2/20 0.51
KDM4E B2RXH2 2/20 0.51
TP53 P04637 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
MAPT P10636 2/20 0.51
MEN1 O00255 1/20 0.51
NPC1 O15118 1/20 0.51
LMNA P02545 1/20 0.51
HSP90AA1 P07900 1/20 0.51
MAPK1 P28482 1/20 0.51
MPI P34949 1/20 0.51
HTT P42858 1/20 0.51
RAB9A P51151 1/20 0.51
KMT2A Q03164 1/20 0.51
HKDC1 Q2TB90 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
CDC7 O00311 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13316086 0.84 PPARG (0.66) PPARG
SCHEMBL7531881 0.84 PPARG (0.55) PPARGALDH1A1KDM4ETP53SMN1; SMN2
SCHEMBL7538581 0.81 PPARG (0.72) PPARGALDH1A1KDM4ETP53SMN1; SMN2
SCHEMBL3576647 0.80 PPARG (0.76) PPARGALDH1A1KDM4ETP53SMN1; SMN2
SCHEMBL3570952 0.79 PPARG (0.74) PPARGALDH1A1KDM4ETP53SMN1; SMN2
SCHEMBL17969781 0.78 ALDH1A1 (0.78) PPARGALDH1A1KDM4ETP53SMN1; SMN2
SCHEMBL3577667 0.78 DHODH (0.44) PPARGALDH1A1KDM4ETP53SMN1; SMN2
SCHEMBL8359086 0.77 PPARG (0.63) PPARGALDH1A1KDM4ETP53SMN1; SMN2
SCHEMBL3572575 0.77 PPARG (1.00) PPARGALDH1A1KDM4ETP53SMN1; SMN2
SCHEMBL3572958 0.76 PPARG (0.69) PPARGALDH1A1KDM4ETP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741323-B2 Indene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-06-22 US disclosed
US-20070185109-A1 Idene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2007-08-09 US disclosed
EP-1740531-A1 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF Korea Research Institute of Chemical Technology (KR) 2007-01-10 EP disclosed
WO-2005100303-A1 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185109-A1 Idene derivatives and process for the preparation thereof INSR, PPARD, GPR119 PPARG 5/4885ALDH1A1 940/4885KDM4E 952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.